Distrubances of neuromuscular interaction may contribute to muscle weakness in spinal muscular atrophy

1997 ◽  
Vol 7 (6-7) ◽  
pp. 369-372 ◽  
Author(s):  
Linda Greensmith ◽  
Gerta Vrbová
2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Xiu-Fen Liu ◽  
Dong-Xin Wang ◽  
Daqing Ma

Spinal muscular atrophy (SMA) is a rare genetic disease characterized by degeneration of spinal cord motor neurons, which results in hypotonia and muscle weakness. Patients with type IV SMA often have onset of weakness from adulthood. Anesthetic management is often difficult in these patients as a result of muscle weakness and hypersensitivity to neuromuscular blocking agents as shown by (Lunn and Wang; 2008, Simic; 2008, and Cifuentes-Diaz et al.; 2002). Herein we report a case of anesthetic management of a patient with SMA type IV for mammectomy and review some other cases of SMA patients receiving different kinds of anesthesia.


2008 ◽  
Vol 27 (4) ◽  
pp. 661-668 ◽  
Author(s):  
Zlatko Matjačić ◽  
Andrej Olenšek ◽  
Janez Krajnik ◽  
Bruno Eymard ◽  
Anton Zupan ◽  
...  

2013 ◽  
Vol 3 (1) ◽  
pp. 24 ◽  
Author(s):  
Justin G Boyer ◽  
Lyndsay M Murray ◽  
Kyle Scott ◽  
Yves De Repentigny ◽  
Jean-Marc Renaud ◽  
...  

2020 ◽  
Vol 7 (4) ◽  
pp. 459-466
Author(s):  
Rafael Rodriguez-Torres ◽  
Julia Fabiano ◽  
Ashley Goodwin ◽  
Ashwini K. Rao ◽  
Stacy Kinirons ◽  
...  

Background: Individuals with spinal muscular atrophy (SMA) III walk independently, but experience muscle weakness, gait impairments, and fatigue. Although SMA affects proximal more than distal muscles, the characteristic pattern of selective muscle weakness has not been explained. Two theories have been proposed: 1) location of spinal motor neurons; and 2) differences in segmental innervation. Objective: To identify neuroanatomical models that explain the selective muscle weakness in individuals with SMA and assess the relationship of these models to ambulatory function. Methods: Data from 23 ambulatory SMA participants (78.2% male), ages 10–56 years, enrolled in two clinical studies (NCT01166022, NCT02895789) were included. Strength was assessed using the Medical Research Council (MRC) score; ambulatory function was measured by distance walked on the 6-minute walk test (6 MWT). Three models were identified, and relationships assessed using Pearson correlation coefficients and linear regression. Results: All models demonstrated a positive association between strength and function, (p < 0.02). Linear regression revealed that Model 3B, consisting of muscles innervated by lower lumbar and sacral segments, explained 67% of the variability observed in 6 MWT performance (β= 0.670, p = 0.003). Conclusions: Muscles innervated by lower lumbar and sacral segments, i.e. hip extensors, hip abductors, knee flexors and ankle dorsiflexors, correlated with and predicted greater ambulatory function. The neuroanatomical patterns of muscle weakness may contribute to a better understanding of disease mechanisms and enable delivery of targeted therapies.


2017 ◽  
Vol 48 (04) ◽  
pp. 273-281 ◽  
Author(s):  
Janbernd Kirschner ◽  
Astrid Pechmann

AbstractSpinal muscular atrophy (SMA) is an autosomal-recessive, neuromuscular disorder that is characterized by degeneration of the anterior horn cells of the spinal cord, resulting in muscle atrophy and proximal muscle weakness. SMA is caused by a homozygous deletion in the survival motor neuron 1 (SMN1) gene on chromosome 5q13. The SMN gene region also comprises a centromeric copy containing the SMN2 gene. The severity of the disease correlates with age of onset and SMN2 copy number and varies from a severe muscle weakness with tetraplegia in infants to a mild proximal muscle weakness in ambulant children. Due to lack of a curative treatment, the care of children with SMA consists mostly of a multidisciplinary treatment including respiratory, nutritional, and orthopaedic management. During the past years, there has been a promising approach for the development of drugs intervening the pathophysiology of SMA with the main idea of upregulating the levels of functional SMN protein. Here, we summarize recent studies regarding diagnosis and treatment avenues in SMA.


Sign in / Sign up

Export Citation Format

Share Document